PMEF
DXCM icon

Point72 Middle East FZE’s DexCom DXCM Stock Holding History

Point72 Middle East FZE’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-39,190
Closed -$4.86M – 402
2023
Q4 		$4.86M Sell
39,190
-135,790
-78% -$13.9M 0.14% 183
2023
Q3 		$16.3M Buy
174,980
+164,713
+1,604% +$18.6M 0.53% 30
2023
Q2 		$1.32M Sell
10,267
-38,433
-79% -$4.65M 0.04% 504
2023
Q1 		$5.66M Sell
48,700
-41,193
-46% -$4.61M 0.19% 138
2022
Q4 		$10.2M Buy
+89,893
New +$9.87M 0.45% 29

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Point72 Middle East FZE's DXCM Position: Q1 2024 in Review

Point72 Middle East FZE sold out of DexCom (DXCM) in Q1 2024, closing a stake of 39,190 shares — an estimated $4.86M sold.

Point72 Middle East FZE first reported a position in DXCM in Q4 2022 and held it in 5 quarters. The position peaked at $16.3M in Q3 2023. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Point72 Middle East FZE reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 39,190 DexCom shares in Q1 2024, an estimated $4.86M.
  • Point72 Middle East FZE first reported a position in DexCom in Q4 2022 and held it in 5 quarters.
  • Point72 Middle East FZE's DexCom position peaked at $16.3M in Q3 2023.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.